[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334773-105":59,"doc-detail-334773-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prognostic-value-of-b7h4-expression-in-patients-with-solid-cancers-a-systematic-review-and-meta-analysis","Prognostic Value of B7H4 Expression in Patients with Solid Cancers - A Systematic Review and Meta-Analysis","","V-set domain-containing T-cell activation inhibitor 1 (aliases VTCN1, B7H4) contributes to tumour immune escape by delivering inhibitory signals to T cells. This work evaluates the prognostic relevance of B7H4 across solid cancers through a systematic search of three databases and pooled hazard ratios. Primary endpoints include overall survival (OS), disease-specific survival (DSS), progression-free survival (PFS), recurrence-free survival (RFS), and disease-free survival (DFS).",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-value-of-b7h4-expression-in-patients-with-solid-cancers-a-systematic-review-and-meta-analysis/334773/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-value-of-b7h4-expression-in-patients-with-solid-cancers-a-systematic-review-and-meta-analysis/334773.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is B7H4 and what role does it play in tumour immunity?","Question",{"text":112,"@type":113},"B7H4 (VTCN1) is a B7-family immune checkpoint. It inhibits T-cell effector function and is broadly overexpressed in many cancers, helping tumours evade immune surveillance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which survival outcomes are analyzed in this systematic review and meta-analysis?",{"text":117,"@type":113},"The main endpoints are overall survival (OS), disease-specific survival (DSS), progression-free survival (PFS), recurrence-free survival (RFS), and disease-free survival (DFS).",{"name":119,"@type":110,"acceptedAnswer":120},"How does high B7H4 expression relate to prognosis in patients with solid cancers?",{"text":121,"@type":113},"High B7H4 expression is associated with worse overall survival (OS). It is not clearly associated with DSS, RFS, DFS, or PFS based on the reported pooled hazard ratios.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334773,1790164527,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nPrognostic Value of B7H4 Expression in Patients with Solid Cancers: A Systematic Review and Meta-Analysis  \nMiriam Dawidowicz 1,*, Agnieszka Kula 1, Sylwia Mielcarska 2, Elbieta ´Swi˛etochowska 2  \nand Dariusz Waniczek 1, *  \n1 Department of Oncological Surgery, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808 Katowice, Poland; [d201070@365.sum.edu.pl](d201070@365.sum.edu.pl)  \n2 Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-800 Zabrze, Poland; [d201109@365.sum.edu.pl](d201109@365.sum.edu.pl) (S.M.); [eswietochowska@365.sum.edu.pl](eswietochowska@365.sum.edu.pl) (E.´S .)  \n* Correspondence: [d201069@365.sum.edu.pl](d201069@365.sum.edu.pl) (M.D.); [dwaniczek@365.sum.edu.pl](dwaniczek@365.sum.edu.pl) (D.W.)  \nAbstract: V-set domain-containing T-cell activation inhibitor 1 (aliases VTCN1, B7H4) participates in tumour immune escape by delivering inhibitory signals to T cells. The purpose of this article was to assess the B7H4 prognostic value in solid cancers. Three databases were searched for relevant articles. The main endpoints were overall survival (OS), disease-speciﬁc survival (DSS), progression-free survival (PFS), recurrence-free survival (RFS), and disease-free survival (DFS) . Appropriate hazard ratios (HRs) were pooled. The R studio software (version 4.0.3) was used for data analysis. Thirty-one studies met the inclusion criteria. High expression of B7H4 was associated with worse OS (HR = 1.52, 95% CI: 1.37–1.68) but not with DSS (HR = 1.14, 95% CI: 0.49–2.63), RFS (HR = 1.77, 95% CI: 0.75–4.18), DFS (HR = 1.29, 95% CI: 0.8–2.09), or PFS (HR = 1.71, 95% CI: 0.91–3.2) in patients with solid cancers. High expression of B7H4 is associated with a poorer prognosis in patients with solid cancers. B7H4 is a promising prognostic biomarker and immunotherapeutic target for various solid cancers because of its activity in cancer immunity and tumourigenesis.  \nCitation: Dawidowicz, M.; Kula, A.; Mielcarska, S.; ´Swi˛etochowska, E.; Waniczek, D. Prognostic Value of B7H4 Expression in Patients with Solid Cancers: A Systematic Review and Meta-Analysis. Int. J. Mol. Sci.  \n2024, 25, 5045. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms25095045](10.3390/ijms25095045)  \nAcademic Editor: Laura Francesca Pisani  \nReceived: 8 April 2024  \nRevised: 27 April 2024  \nAccepted: 2 May 2024  \nPublished: 6 May 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nKeywords: B7H4; cancer prognosis; immune checkpoint; solid cancers  \n1. Introduction  \n1.1. B7H4 Expression and Function  \nB7H4 is a member of the B7 immune checkpoint family. The immune checkpoints are regulators of the immune system and are crucial for self-tolerance [1] . B7H4 is a coinhibitory ligand that exerts its function by suppressing the T cell effector function, while its molecule interaction on T cells remains unknown. B7H4 is broadly overexpressed in human cancers, including lung, liver, kidney, ovary, stomach, skin, pancreas, colorectal, and breast cancers, and is exploited by tumour in order to evade immune surveillance [2–6] .  \n1.2. B7H4 in Solid Cancers  \nB7H4 is predominantly expressed on antigen-presenting cells (APCs) and tumour cells. Its heightened activity in cancer is associated with the increased inﬁltration of immunosuppressive cells and elevated production of regulatory T cells, leading to a reduced proliferation and effector function of CD4+ and CD8+ T cells [7] . Contrary to PD-L1, which is expressed in about 30% or even fewer patients and is associated with immunologically“hot” tumours, the expression of B7H4 marks a “col","cbCaimRwLtNsp4rr","https://ap.wps.com/l/cbCaimRwLtNsp4rr","pdf",3242124,14,"English","# Introduction\n## B7H4 Expression and Function\n## B7H4 in Solid Cancers","[{\"question\":\"What is B7H4 and what role does it play in tumour immunity?\",\"answer\":\"B7H4 (VTCN1) is a B7-family immune checkpoint. It inhibits T-cell effector function and is broadly overexpressed in many cancers, helping tumours evade immune surveillance.\"},{\"question\":\"Which survival outcomes are analyzed in this systematic review and meta-analysis?\",\"answer\":\"The main endpoints are overall survival (OS), disease-specific survival (DSS), progression-free survival (PFS), recurrence-free survival (RFS), and disease-free survival (DFS).\"},{\"question\":\"How does high B7H4 expression relate to prognosis in patients with solid cancers?\",\"answer\":\"High B7H4 expression is associated with worse overall survival (OS). It is not clearly associated with DSS, RFS, DFS, or PFS based on the reported pooled hazard ratios.\"}]","Prognostic Value of B7H4 Expression in Patients with Solid Cancers - A Systematic Review and Meta-Analysis | PDF",1790008333,35]